Search Results 201-210 of 2775 for ⚖[광고텔레:SEOGOT] 구글슬롯사이트홍보 구글카지노사이트홍보 대포통장 구글오피사이트홍보 달림폰 구글찌라시배포⚖

1. A Study to Assess the Added Value of CTA in the Algorithm for Management of Acute Lower GI Bleeding - Mayo Clinic

   Additional contact information. Non-cancer trials contact form. Phone: 800-664-4542 (toll-free). International patient clinical studies questions. Phone: 507- ...

2. A Study of the Use of Smartphone Videos to Aid in Evaluation of Epileptic Seizures - Mayo Clinic

   Phone: 800-664-4542 (toll-free). International patient clinical studies questions. Phone: 507-284-8884; Email: intl.mcr@mayo.edu. More about research at Mayo ...

3. Automated 3-D Model Creation for Glenoid Bone Stock Evaluation on CT Shoulder Exams - Mayo Clinic

   About this study. We hypothesize that an AI algorithm can automate the segmentation of the process to provide an initial contour for these structures that ...

4. PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial

   Additional contact information. Non-cancer trials contact form. Phone: 800-664-4542 (toll-free). International patient clinical studies questions. Phone: 507- ...

5. A Study to Evaluate Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer - Mayo Clinic

   A Study to Evaluate Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer.

6. Study of rSIFN-co for Patients with Advanced Solid Tumors - Mayo Clinic

   The purpose of this study is to evaluate the safety, disease response, and drug /body interactions of rSIFN-co at different dose levels to demonstrate optimal ...

7. Mine Cicek, Ph.D. - Mayo Clinic Faculty Profiles

   Molecular cancer genetic epidemiologist Mine Cicek, Ph.D., leads the Mayo Clinic Biorepositories Program.

8. A Study to Evaluate the Long Term Safety of Titrated Immediate-Release Tolvaptan in Subjects with Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

   A Study to Evaluate the Long Term Safety of Titrated Immediate-Release Tolvaptan in Subjects with Autosomal Dominant Polycystic Kidney Disease.

9. Stewardship, AMR Technology, and Ethics - Mayo Clinic

   About this study. The purpose of this study is to explore ethical, legal, and social implications (ELSI) of stakeholder attitudes toward new genomic ...

10. Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDS - Mayo Clinic

    Mocetinostat is an orally administered histone deacetylase (HDAC) inhibitor. Azacitidine is a hypomethylating agent (HMA) used to treat MDS. In this study, ...